Back to ?7 soon16 May 2018 15:25
The CEO seems to be excited about the Japanese Study which will boost the share price once those results are released. Also the CEO seems to be surprised about the Traumakine announcement despite the previous positive encouraging results? Was there possibly a calculation error in significance level? I think so. This should go to �2 per share short term